Reconsideration of American Society of Clinical Oncology/American Society of Hematology Erythropoiesis-stimulating Agent Guidelines.
Murray
Nevin
N
Klasa
Richard
R
D006397:Hematinics / Q000009:adverse effects* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000097:blood; D017410:Practice Guidelines as Topic; D014481:United States; D014486:United States Food and Drug Administration
D006397:Hematinics; D006454:Hemoglobins